نتایج جستجو برای: malignant hematologic disorders

تعداد نتایج: 883437  

Journal: :Blood 1992
M Mittelman S Floru M Djaldetti

We have used recombinant human erythropoietin (rHuEPO) in a phase 1/11 clinical trial to evaluate its ability to reverse refractory anemia in hematologic disorders. rHuEPO was administered subcutaneously 5 days per week at escalating doses (50 t o 150 U/kg per day). The aim of treatment was a hemoglobin (Hb) level 2 10 g/dL without blood transfusion. Of 25 patients treated, 17 were evaluable, m...

2011
Moon Ju Jang Hyeon Jin Park Sung-Soo Yoon Je-Hwan Lee Kyung-Duk Park Seok-Jin Kim Ho-Joon Im Jin-Seok Kim Jun-Ho Jang Suk-Joong Oh Hee-Soon Cho Jae-Woo Song Yeon-Jung Lim Ho-Young Kim

Korean National Health Insurance (NHI) was introduced in 1963 and became a nationwide health insurance after several law reforms in 1988. As a result of nationalization, coverage has expanded, and its service level has greatly improved since 1998 [1]. However, several diagnostic and therapeutic modalities for rare, incurable diseases such as malignant hematologic diseases are excluded from the ...

2003
Mario Cazzola Luisa Ponchio Yves Beguin Vittorio Rosti Gaetano Bergamaschi Vittorio Fregoni Giulio Nalli Giovanni Barosi Edoardo Ascari

We have used recombinant human erythropoietin (rHuEPO) in a phase 1/11 clinical trial to evaluate its ability to reverse refractory anemia in hematologic disorders. rHuEPO was administered subcutaneously 5 days per week at escalating doses (50 t o 150 U/kg per day). The aim of treatment was a hemoglobin (Hb) level 2 10 g/dL without blood transfusion. Of 25 patients treated, 17 were evaluable, m...

2014
Sarah K. Tasian David T. Teachey Susan R. Rheingold

A complex interplay of intracellular signaling networks orchestrates normal cell growth and survival, including translation, transcription, proliferation, and cell cycle progression. Dysregulation of such signals occurs commonly in many malignancies, thereby giving the cancer cell a survival advantage, but also providing possible targets for therapeutic intervention. Activation of the phosphati...

Journal: :Haematologica 2005
Helga M Ogmundsdóttir Vilhelmína Haraldsdóttirm Gudmundur M Jóhannesson Gudrídur Olafsdóttir Kristín Bjarnadóttir Helgi Sigvaldason Hrafn Tulinius

BACKGROUND AND OBJECTIVES The occurrence of two or more cases of multiple myeloma (MM) in the same family has been reported from time to time. The current study is the first population- and cancer-registry-based survey to investigate familiality of premalignant or malignant B-cell proliferation. DESIGN AND METHODS A family registry of 218 multiple myeloma cases was compared with the records o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید